Inhibrx, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
47.83
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.94
|
-0.90
|
0.04
|
4.26%
|
|
2022-06-30
|
-0.78
|
-0.97
|
-0.19
|
-24.36%
|
|
2022-03-31
|
-0.60
|
-0.80
|
-0.20
|
-33.33%
|
|
2021-12-31
|
-0.57
|
-0.55
|
0.02
|
3.51%
|
|
2021-09-30
|
-0.57
|
-0.54
|
0.03
|
5.26%
|
|
2021-06-30
|
-0.56
|
-0.55
|
0.01
|
1.79%
|
|
2021-03-31
|
-0.59
|
-0.51
|
0.08
|
13.56%
|
|
2020-12-31
|
-0.54
|
-0.47
|
0.07
|
12.96%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.67
|
|
2021-12-31
|
-2.15
|
|
2020-12-31
|
-4.25
|